Albuminuria by diabetes mellitus: Marker and motor of diabetic nephropathy and vascular complications

被引:0
|
作者
Hunger-Dathe W. [1 ,2 ]
Wolf G. [1 ]
机构
[1] Klinik für Innere Medizin III, Klinikum, Friedrich-Schiller-Universität, Jena
[2] Klinik für Innere Medizin III, Klinikum, Friedrich-Schiller-Universität
来源
Der Diabetologe | 2006年 / 2卷 / 5期
关键词
Cardiovascular morbidity; Diabetic nephropathy; Microalbuminuria; Myocardial infarct; Stroke;
D O I
10.1007/s11428-006-0069-z
中图分类号
学科分类号
摘要
Diabetic nephropathy requires intensive treatment as it is the main reason for the morbidity and mortality resulting from diabetes mellitus. Patients with diabetic nephropathy have a significantly higher mortality rate due to cardiovascular events such as myocardial infarct or stroke. Microalbuminuria is the earliest clinical sign of diabetic renal disease and is also a marker for increased cardiovascular morbidity and mortality. Thus, its early detection allows not only for effective secondary prevention of the progression of diabetic nephropathy, but is also an indication for the implementation of an individually-tailored cardiovascular risk reduction management program. People with diabetes mellitus are high risk patients who need intensive monitoring and intensive supportive therapy. © Springer Medizin Verlag 2006.
引用
收藏
页码:400 / 409
页数:9
相关论文
共 50 条
  • [41] Targeting Autophagy: A Promising Therapeutic Strategy for Diabetes Mellitus and Diabetic Nephropathy
    Li, Qi-Rui
    Xu, Hui-Ying
    Ma, Rui-Ting
    Ma, Yuan-Yuan
    Chen, Mei-Juan
    DIABETES THERAPY, 2024, 15 (10) : 2153 - 2182
  • [42] Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus
    Dierk H. Endemann
    Ernesto L. Schiffrin
    Current Hypertension Reports, 2004, 6 : 85 - 89
  • [43] Identification of the Locus Associated with Diabetic Nephropathy in Type 1 Diabetes Mellitus
    K. V. Savost'yanov
    D. A. Chistyakov
    M. V. Shestakova
    O. E. Voron'ko
    L. A. Chugunova
    M. Sh. Shamkhalova
    I. I. Dedov
    V. V. Nosikov
    Molecular Biology, 2002, 36 : 823 - 827
  • [44] EARLY MARKERS OF DIABETIC NEPHROPATHY IN CHILDREN WITH TYPE 1 DIABETES MELLITUS
    Khmadov, G. A.
    WORLD OF MEDICINE AND BIOLOGY, 2022, 81 (03): : 13 - 17
  • [45] Early onset of diabetic nephropathy in a child with type 1 diabetes mellitus
    Bayazit, AK
    Yüksel, B
    Noyan, A
    Önenli, N
    Gönlüsen, G
    Özer, G
    Anarat, A
    TURKISH JOURNAL OF PEDIATRICS, 2003, 45 (01) : 55 - 58
  • [46] Progression of diabetic nephropathy in Saudi patients with type 2 diabetes mellitus
    Al Suleiman, Mohamed H.
    Kfoury, Hala K.
    Jondeby, Mohamed S.
    Burgos, Noel S.
    Al Hayyan, Hajjar
    Al Sayyari, Abdulla
    ENDOCRINOLOGIST, 2008, 18 (05) : 230 - 232
  • [47] Identification of the locus associated with diabetic nephropathy in type 1 diabetes mellitus
    Savost'yanov, KV
    Chistyakov, DA
    Shestakova, MV
    Voron'ko, OE
    Chugunova, LA
    Shamkhalova, MS
    Dedov, II
    Nosikov, VV
    MOLECULAR BIOLOGY, 2002, 36 (06) : 823 - 827
  • [48] COULD PROTEINURIA PREDICT THE RENAL PROGNOSES OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND DIABETIC NEPHROPATHY?
    Wang, J. L.
    Sun, Y.
    Wang, Y.
    Wu, Y.
    Liu, F.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2022, 18 (01) : 29 - 34
  • [49] Incidence of diabetic nephropathy in patients with type 2 diabetes mellitus at a tertiary healthcare setting in Ethiopia
    Tamru, Kidist
    Aga, Fekadu
    Berhanie, Emebet
    Aynalem, Yared Asmare
    Shiferaw, Wondimeneh Shibabaw
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (05) : 1077 - 1083
  • [50] Diabetic nephropathy in type II diabetes
    Ritz, E
    Stefanski, A
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (02) : 167 - 194